Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?

The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (<i>p</i> = 0.0481 and <i>p</i> < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (<i>p</i> = 0.0029). <b>Conclusions:</b> Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.

Authors

Institutions

Publication Details

Journal
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Published
2025-01-01
DOI
https://doi.org/10.32604/or.2025.055306
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?

William Carlos Nahas, Iran Amorim Silva, Juliana Alves de Camargo, Ruan Pimenta et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Bladder and Urothelial Cancer Treatments
article

Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?

William Carlos Nahas, Iran Amorim Silva, Juliana Alves de Camargo, Ruan Pimenta, Nayara Izabel Viana, Karina Serafim da Silva, Sabrina T Reis, Patrícia Candido, Kátia Ramos Moreira Leite, Carolina Mie Mioshi, Vanessa Guimarães, Gabriel Arantes dos Santos, Poliana Romão, Fernando Cotait Maluf, Tiago André Moura Rodrigues
article en

Abstract

The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (<i>p</i> = 0.0481 and <i>p</i> < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (<i>p</i> = 0.0029). <b>Conclusions:</b> Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.

Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsVol. 33(6)
Federal Institute of São Paulo (BR), Morpho (United States) (US), Universidade do Estado de Minas Gerais (BR), Instituto do Câncer do Estado de São Paulo (BR), D’Or Institute for Research and Education (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Centro Universitário São Camilo (BR)
Zero hunger
Openalex Percentile: Top 89%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer? — William Carlos Nahas, Iran Amorim Silva, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2025) | TGRS Research Map | TGRS